|
Volumn 3, Issue 3, 2005, Pages 577-580
|
Hypercoagulability preceding cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOPOIETIN 1;
ANGIOPOIETIN 2;
ANGIOPOIETIN RECEPTOR;
ANTICOAGULANT AGENT;
ANTINEOPLASTIC AGENT;
ANTIVITAMIN K;
BLOOD CLOTTING FACTOR 10A;
BLOOD CLOTTING FACTOR 7;
FERRITIN;
FIBRINOPEPTIDE A;
FIBRONECTIN;
GLYCOSAMINOGLYCAN;
GROWTH FACTOR;
HEPARIN;
HIRUDIN;
IRON;
LOW MOLECULAR WEIGHT HEPARIN;
PROTEINASE ACTIVATED RECEPTOR 1;
THROMBIN;
THROMBOMODULIN;
VASCULOTROPIN;
VASCULOTROPIN RECEPTOR 2;
VON WILLEBRAND FACTOR;
WARFARIN;
ANTICOAGULANT THERAPY;
ANTINEOPLASTIC ACTIVITY;
CANCER RISK;
CARCINOGENESIS;
CYTOKINE RELEASE;
DORMANCY;
HUMAN;
HYPERCOAGULABILITY;
LUNG METASTASIS;
LUNG SMALL CELL CANCER;
MICROENVIRONMENT;
MOUTH CANCER;
PRIORITY JOURNAL;
REVIEW;
THROMBIN TIME;
THROMBOPHLEBITIS;
TUMOR CELL;
VENOUS THROMBOEMBOLISM;
ANIMAL;
ARTICLE;
NEOPLASM;
PATHOLOGY;
PHYSIOLOGY;
PREVALENCE;
THROMBOPHILIA;
VEIN THROMBOSIS;
ANIMALS;
HUMANS;
NEOPLASMS;
PREVALENCE;
THROMBIN;
THROMBOPHILIA;
VENOUS THROMBOSIS;
|
EID: 23944466494
PISSN: 15387933
EISSN: 15387836
Source Type: Journal
DOI: 10.1111/j.1538-7836.2005.01174.x Document Type: Review |
Times cited : (23)
|
References (0)
|